in situ BCG-refractory Bladder carcinoma (DBCOND0021072)
Identifiers
- Synonyms
- Not Available
Associated Data
- Indicated Drugs and Targets
Drug Description Targets Valrubicin An anthracycline used intravesically in the treatment of BCG-resistant bladder carcinoma.- DNA topoisomerase 2-alphatarget
- DNAtarget
- DNA topoisomerase 2-betatarget
- Clinical Trials
- Not Available